Typhoid Antibody Testing Market Segmentation:
End Users Segment Analysis
The hospital segment in the typhoid antibody testing market is anticipated to garner the largest revenue share of 29% over the forecast period owing to the availability of proper medical facilities on hospital premises and the availability of advanced technologies and treatment. Besides this, the surge in the medical and tourism industry is also projected to generate numerous growth opportunities for the segment in the coming years. As per the Medical Tourism Association, about 14 million people in the world travel to other countries in search of medical care annually. Moreover, fast-paced, advanced technological equipment and people’s trust in a highly qualified professional are estimated to fuel the growth of the segment.
Product Type Segment Analysis
The WIDAL Test segment is projected to hold 40% share of the global typhoid antibody testing market in the forecast year. WIDAL test includes very fewer equipment and can be performed and learned easily. The WIDAL test is an advanced test that checks for antibodies in the body’s reaction to Salmonella typhi which is the core source of typhoid fever. It generally looks for O and H antibodies in the sample blood of patients. Therefore, owing to its advanced characteristics, this segment is expected to witness major growth over the upcoming decades.
Our in-depth analysis of the global typhoid antibody testing market includes the following segments:
|
Product Type |
|
|
End Users |
|
